Bellevue Group AG reduced its stake in Boston Scientific in Q1, now holding 3.3%, while institutional investors own 89.07%.

Bellevue Group AG reduced its stake in Boston Scientific Co. by 0.7% in Q1, now owning 3.3% of the medical equipment provider's shares. Institutional investors own 89.07% of Boston Scientific stock, trading at $74.92 with a 12% net margin and 16.80% return on equity. Kestra Advisory Services, Mutual Advisors, and Raymond James Financial Services Advisors have also increased their stakes in the company.

July 28, 2024
4 Articles

Further Reading